Clinical Trial Update: Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial [NA]

View source ↗

Summary

This clinical trial update describes a Phase II study evaluating two-fraction proton therapy with MRI guidance for prostate cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Hong Kong Sanatorium & Hospital | Conditions: Prostate Cancer Patients Treated by Radiotherapy | NA | Status: RECRUITING